# Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)

> **NCT00712049** · PHASE4 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 200 (estimated)

## Conditions studied

- Dyslipidemia
- Atherosclerosis

## Interventions

- **DRUG:** simvastatin
- **DRUG:** Nicotinic Acid

## Key facts

- **NCT ID:** NCT00712049
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2011-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00712049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00712049, "Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00712049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*